Regulatory News: This replaces the announcement made at 8:58 AM CET on November 5th, 2025 due to corrections. Poxel: Update on the Draft Recovery Plan and Co… LYON, France–(BUSINESS WIRE)&...
Regulatory News: POXEL SA (Euronext : POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious … LYON, France–(BUSINESS ...
